Biotage AB (publ) (OM:BIOT) acquired ATDBio Ltd for ?45 million on October 20, 2021. The consideration will be in cash and stock and is on a debt free and cash free basis. ?16 million(approx. SEK 190 million) in 781991 for all newly issued shares in biotage and approx. ?29 million(approx. SEK 344.4 million) in cash. whereof ?5 million(corresponding to approx. SEK 59.4 million) of the total purchase price consist of an expected future additional purchase price payment which at outcome is to be paid out after three years. The transaction will be financed through a share issue of 781,991 new ordinary Biotage shares combined with cash at hand and a revolving credit facility. ATDBio generated net sales of ?3.5 million(corresponding to approx. SEK 41.6 million) and EBIT of ?1 million(corresponding to approx. SEK 11.9 million) in 2020. Biotage AB (publ) (OM:BIOT) completed the acquisition of ATDBio Ltd on October 20, 2021.